![Man Hong Tam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Man Hong Tam
Finanzdirektor/CFO bei QuantumPharm, Inc.
Aktive Positionen von Man Hong Tam
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
QuantumPharm, Inc.
![]() QuantumPharm, Inc. BiotechnologyHealth Technology QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China. | Finanzdirektor/CFO | 01.12.2020 | - |
Unternehmenssekretär | 27.11.2023 | - | |
Hong Kong Institute of Certified Public Accountants
![]() Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01.01.2003 | - |
Karriereverlauf von Man Hong Tam
Ehemalige bekannte Positionen von Man Hong Tam
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HUYA Bioscience International LLC
![]() HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 01.10.2020 | 01.11.2020 |
UBS | Vorstandsvorsitzender | 01.07.2018 | 01.07.2020 |
BOSC International Co. Ltd.
![]() BOSC International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bank of Shanghai Co., Ltd., BOSC International Co. Ltd. provides financial consulting services. The company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Chi Wah Lau. | Vorstandsvorsitzender | 01.02.2017 | 01.05.2018 |
Guosen Securities (HK) Financial Holdings Co., Ltd. | Vorstandsvorsitzender | 01.02.2016 | 01.01.2017 |
Jefferies Hong Kong Ltd.
![]() Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Vorstandsvorsitzender | 01.12.2011 | 01.11.2015 |
UBS AG (Hong Kong Branch)
![]() UBS AG (Hong Kong Branch) Investment Banks/BrokersFinance Part of UBS Group AG, UBS AG (Hong Kong Branch) is a Chinese company that provides investment banking securities dealing services. The company is based in Hong Kong, Hong Kong. | Direktor/Vorstandsmitglied | 01.08.2007 | 01.09.2011 |
Ausbildung von Man Hong Tam
Auckland University | Undergraduate Degree |
University of Cambridge | Graduate Degree |
Statistik
International
Hong Kong | 6 |
China | 2 |
Neuseeland | 2 |
Operativ
Chief Executive Officer | 4 |
Director of Finance/CFO | 2 |
Corporate Secretary | 1 |
Sektoral
Finance | 4 |
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
![]() | Health Technology |
Private Unternehmen | 7 |
---|---|
UBS AG (Hong Kong Branch)
![]() UBS AG (Hong Kong Branch) Investment Banks/BrokersFinance Part of UBS Group AG, UBS AG (Hong Kong Branch) is a Chinese company that provides investment banking securities dealing services. The company is based in Hong Kong, Hong Kong. | Finance |
Jefferies Hong Kong Ltd.
![]() Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Finance |
Guosen Securities (HK) Financial Holdings Co., Ltd. | |
BOSC International Co. Ltd.
![]() BOSC International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bank of Shanghai Co., Ltd., BOSC International Co. Ltd. provides financial consulting services. The company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Chi Wah Lau. | Commercial Services |
UBS AG
![]() UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
HUYA Bioscience International LLC
![]() HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Hong Kong Institute of Certified Public Accountants
![]() Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Commercial Services |
- Börse
- Insiders
- Man Hong Tam
- Erfahrung